Analysis: Alembic Limited

NSE:ALEMBICLTD Finance - Holding Company Market cap: ₹2.9K cr

What does Alembic Limited do?

  • Alembic Limited is a diversified Indian company with operations in Active Pharmaceutical Ingredients (API) manufacturing and Real Estate development.
  • The company is headquartered in Vadodara, Gujarat, and has been in operation since 1967 under the leadership of the Amin family.
  • The company's chairman, Mr. Chirayu Amin, has over five decades of experience in managing and growing the business.
  • API Business: Manufacturing and supply of Active Pharmaceutical Ingredients (APIs) for global and domestic markets.
  • Real Estate Business: Development of residential and commercial properties, including Alembic City, a flagship integrated township project.

Growth thesis

Alembic Ltd operates as a finance holding company focused on capital allocation and strategic investment management. Its business model centers on optimizing returns through oversight of financial services subsidiaries, though specific segments remain undisclosed. Growth is indirectly tied to India’s expanding digital banking and SME credit markets, as highlighted in thematic exposures. Over 2-3 years, performance will depend on macroeconomic tailwinds and management’s ability to deploy capital effectively in a competitive financial services landscape. Key risks include regulatory shifts and capital efficiency in a structure with limited operational transparency.

Research report

companyname: Alembic Limited ticker: ALEMBICLTD sector: Real Estate Development and Bulk Drugs (API Manufacturing) Alembic Limited, incorporated in 1907 and headquartered at Alembic Road in Vadodara, Gujarat, runs two businesses that share little besides a name and a campus. It develops and leases real estate within the Alembic City township built on its former pharmaceutical manufacturing site, and it manufactures active pharmaceutical ingredients (APIs) and intermediates at a plant on the sam...

Read the full report →
RS rating: 88 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Alembic Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.